Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
VANCOUVER, British Columbia, May 29, 2019 (GLOBE NEWSWIRE) -- Broome Capital Inc. (TSXV: BCP) (the “Company”) is pleased to announce that it has received conditional acceptance for its planned...
In the news release, American Stock Exchange Lists the Common Stock of Brooke Capital Corporation, issued earlier today by American Stock Exchange over PR Newswire, we are advised by the company...
NEW YORK, Aug. 30 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today lists the common stock of Brooke Capital Corporation under ticker symbol BCP. Brooke Capital Corporation is a...
NEW HAMPTON, N.Y., Aug. 10 /PRNewswire-FirstCall/ -- Balchem Corporation today announced that Akash Tayal, Ph.D., has joined the company in the position of Principle Scientist in the Research...
Balchem Corporation Joins Russell 3000 Index NEW HAMPTON, N.Y., July 5 /PRNewswire-FirstCall/ -- Balchem Corporation joined the Russell 3000(R) Index, the small-cap Russell 2000(R) Index and the...
Dr. John Televantos, PhD. Joins Balchem's Board of Directors NEW HAMPTON, N.Y., Feb. 21 /PRNewswire-FirstCall/ -- The Directors of Balchem Corporation are pleased to announce the expansion of the...
Balchem Corporation Announces Extension of Stock Repurchase Program NEW HAMPTON, N.Y., June 21 /PRNewswire-FirstCall/ -- Balchem Corporation today announced that its Board of Directors has...
Balchem Appoints Bob Van Der Schaaf Western Region Technical Sales Representative for its Animal Nutrition & Health Business NEW HAMPTON, N.Y., April 20 /PRNewswire-FirstCall/ -- Balchem...
Balchem Corporation Releases Third Quarter Results NEW HAMPTON, N.Y., Oct. 28 /PRNewswire-FirstCall/ -- Balchem Corporation (BCP - AMEX) Reported as Follows (Unaudited) for the Quarter Ended...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
